Newcells Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Newcells biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Newcells Biotech Today - Breaking & Trending Today

Newcells Biotech Raises Further £2.35M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

City Of , United Kingdom , Mike Nicholds , European Regional Development Fund , Venture Fund , Newcells Biotech , United Kingdom Based , North East Venture Fund , Mercia Ventures ,

Over £12m now raised following new investment at North East biotech

Newcastle’s Newcells Biotech, whose laboratory models are used in drug development and reduce reliance on animal testing, has raised a further £2.35m. ....

Mike Nicholds , Lyle Armstrong , Alex Simpson , University Of Newcastle , Venture Fund , European Regional Development Fund , Newcells Biotech , North East Venture Fund , Mercia Ventures , Professor Lyle , Northern Venture Capital ,

Doubling Down On Gain Therapeutics (NASDAQ:GANX)

Doubling Down On Gain Therapeutics (NASDAQ:GANX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , Hans Peter Hassler , Grifol Prolastin , Khalid Islam , Derek Lowe , Vanqua Bio , Steve Cohen , Matthias Alder , Andrew Schwartzberg , David Einhorn , Claude Nicaise , Sumitomo Pharma , Eric Richman , Michaelj Fox Foundation , Institute For Research , Recursion Pharmaceuticals , University Of Helsinki , Digital Molecular Structure , Gain Therapeutics , Truly Valuable , Investment Activity Reduce Financial Risks , Strengthen Investor , Greenlight Capital , Caraway Therapeutics , Closer Look , Potential Best In Class ,

Gain Therapeutics Reports First Quarter 2023 Financial Results and Business Update

Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinson’s diseaseCompany is on track to submit application for start of Phase 1 clinical trial of GT-02287 to. | May 12, 2023 ....

Vastra Gotalands Lan , Eteläuomen Läi , Matthias Alder , C Evan Ballantyne , Evan Ballantyne , Gain Therapeutics Inc , Company Annual Report On Form , Exchange Commission On , Silverstein Foundation For Parkinson , Human Research Ethics Committee , University Of Helsinki , Institute For Research , European Union Horizon , International Conference On Alzheimer , Exchange Commission , Michaelj Fox Foundation For Parkinson Research , Swiss Innovation Agency , Gain Therapeutics , Chief Financial Officer , Chief Executive , Cell Based Models , Amyloid Beta , Swiss Accelerator , Newcells Biotech , Months Ended March , Silverstein Foundation ,

Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update

23.03.2023 - Company expects completion of IND-enabling studies of GT-02287 in H1 2023Submission of dossier to start Phase 1 clinical trial of GT-02287 in GBA1 Parkinson’s Disease expected by mid-year 2023$22.1 million in cash and cash equivalents and marketable . ....

Eteläuomen Läi , University Of Helsinki , Exchange Commission , Gain Therapeutics Inc , Silverstein Foundation For Parkinson , Exchange Commission On , Michaelj Fox Foundation For Parkinson Research , Company Annual Report On Form , Institute For Research , European Union Horizon , Business Updates , Structurally Targeted Allosteric Regulator , Reduces Microgliosis , Improves Fine Locomotor Skills , Neuronopathic Gaucher , Gain Therapeutics , Newcells Biotech , Ended December , Silverstein Foundation , Private Securities Litigation Reform Act , Annual Report ,